Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Retained Earnings (2016 - 2018)

Armata Pharmaceuticals' Retained Earnings history spans 6 years, with the latest figure at -$402.0 million for Q3 2018.

  • For Q3 2018, Retained Earnings fell 2.59% year-over-year to -$402.0 million; the TTM value through Sep 2018 reached -$402.0 million, down 2.59%, while the annual FY2017 figure was -$394.2 million, 3.37% down from the prior year.
  • Retained Earnings for Q3 2018 was -$402.0 million at Armata Pharmaceuticals, roughly flat from -$400.4 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$360.3 million in Q3 2015 and bottomed at -$402.0 million in Q3 2018.
  • The 5-year median for Retained Earnings is -$382.0 million (2014), against an average of -$380.8 million.
  • The largest annual shift saw Retained Earnings grew 6.0% in 2014 before it dropped 5.84% in 2017.
  • A 5-year view of Retained Earnings shows it stood at -$362.0 million in 2014, then rose by 0.47% to -$360.3 million in 2015, then dropped by 5.85% to -$381.4 million in 2016, then decreased by 3.37% to -$394.2 million in 2017, then fell by 1.98% to -$402.0 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Retained Earnings are -$402.0 million (Q3 2018), -$400.4 million (Q2 2018), and -$397.3 million (Q1 2018).